These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9774678)

  • 1. Substitution of the human beta-spectrin promoter for the human agamma-globin promoter prevents silencing of a linked human beta-globin gene in transgenic mice.
    Sabatino DE; Cline AP; Gallagher PG; Garrett LJ; Stamatoyannopoulos G; Forget BG; Bodine DM
    Mol Cell Biol; 1998 Nov; 18(11):6634-40. PubMed ID: 9774678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human gamma-globin gene promoter element regulates human beta-globin gene developmental specificity.
    Ryan TM; Sun CW; Ren J; Townes TM
    Nucleic Acids Res; 2000 Jul; 28(14):2736-40. PubMed ID: 10908330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene.
    Tewari R; Gillemans N; Harper A; Wijgerde M; Zafarana G; Drabek D; Grosveld F; Philipsen S
    Development; 1996 Dec; 122(12):3991-9. PubMed ID: 9012519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominant expression of human Agamma--in contrast with beta-globin gene in MEL cells transfected with the construct muLCRAgamma psibeta deltabeta.
    Junwu Z; Stamatoyannopoulos G
    Chin Med Sci J; 1999 Mar; 14(1):31-7. PubMed ID: 12899381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.
    Anderson KP; Lloyd JA; Ponce E; Crable SC; Neumann JC; Lingrel JB
    Mol Biol Cell; 1993 Oct; 4(10):1077-85. PubMed ID: 8298193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
    Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
    J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locus control region activity by 5'HS3 requires a functional interaction with beta-globin gene regulatory elements: expression of novel beta/gamma-globin hybrid transgenes.
    Rubin JE; Pasceri P; Wu X; Leboulch P; Ellis J
    Blood; 2000 May; 95(10):3242-9. PubMed ID: 10807795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the gamma-globin gene in adult erythropoiesis.
    Xiang P; Han H; Barkess G; Olave I; Fang X; Yin W; Stamatoyannopoulos G; Li Q
    Hum Mol Genet; 2005 Oct; 14(20):3047-56. PubMed ID: 16155112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of viral vectors for gene therapy of beta-chain hemoglobinopathies: optimization of a gamma-globin gene expression cassette.
    Li Q; Emery DW; Fernandez M; Han H; Stamatoyannopoulos G
    Blood; 1999 Apr; 93(7):2208-16. PubMed ID: 10090929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human locus control region elements HS2 and HS3 on human beta-globin gene expression in transgenic mouse.
    Jia CP; Huang SZ; Yan JB; Xiao YP; Ren ZR; Zeng YT
    Blood Cells Mol Dis; 2003; 31(3):360-9. PubMed ID: 14636653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site.
    Harju-Baker S; Costa FC; Fedosyuk H; Neades R; Peterson KR
    Mol Cell Biol; 2008 May; 28(10):3101-13. PubMed ID: 18347053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin.
    Arcasoy MO; Romana M; Fabry ME; Skarpidi E; Nagel RL; Forget BG
    Mol Cell Biol; 1997 Apr; 17(4):2076-89. PubMed ID: 9121456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
    Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
    J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the beta-like globin genes in transgenic mice is dependent on the presence of the beta-locus control region.
    Navas PA; Li Q; Peterson KR; Swank RA; Rohde A; Roy J; Stamatoyannopoulos G
    Hum Mol Genet; 2002 Apr; 11(8):893-903. PubMed ID: 11971871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An embryonic-specific repressor element located 3' to the Agamma-globin gene influences transcription of the human beta-globin locus in transgenic mice.
    Katsantoni EZ; de Krom M; Kong-a-San J; Imam AM; Grosveld F; Anagnou NP; Strouboulis J
    Exp Hematol; 2004 Feb; 32(2):224-33. PubMed ID: 15102485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5' control region of the human epsilon-globin gene is sufficient for embryonic specificity in transgenic mice.
    Shih DM; Wall RJ; Shapiro SG
    J Biol Chem; 1993 Feb; 268(5):3066-71. PubMed ID: 8428985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.
    Omori A; Tanabe O; Engel JD; Fukamizu A; Tanimoto K
    Mol Cell Biol; 2005 May; 25(9):3443-51. PubMed ID: 15831451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the human beta-globin LCR 5'HS4 or 5'HS1 differentially affects beta-like globin gene expression in beta-YAC transgenic mice.
    Fedosyuk H; Peterson KR
    Blood Cells Mol Dis; 2007; 39(1):44-55. PubMed ID: 17433733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous developmental control of human embryonic globin gene switching in transgenic mice.
    Raich N; Enver T; Nakamoto B; Josephson B; Papayannopoulou T; Stamatoyannopoulos G
    Science; 1990 Nov; 250(4984):1147-9. PubMed ID: 2251502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the hereditary persistence of fetal hemoglobin 2 enhancer to increase the expression of oncoretrovirus vectors for human gamma-globin.
    Fragkos M; Anagnou NP; Tubb J; Emery DW
    Gene Ther; 2005 Nov; 12(21):1591-600. PubMed ID: 15944728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.